- Stock: In Stock
- Brand: Acme Laboratories Limited
- Product ID: Trimetazidine Dihydrochloride
100% Secure Payment
Angirid MR 35 mg Tab
DESCRIPTION
ANGIRID MR (Trimetazidine Hydrochloride) has been proven to exert antianginal properties due to its specific metabolic mechanism of action. Indeed, Trimetazidine Hydrochloride reduces the metabolic damage caused during ischemia, by acting on a critical step in cardiac metabolism: fatty acid β-oxidation. This is made possible by selective inhibition of an enzyme of fatty acid βoxidation: the long-chain 3-ketoacyl CoA thiolase (3-KAT). This inhibition results in reduction in fatty acid oxidation & stimulation of glucose oxidation. Thus, the coupling of glycolysis with glucose oxidation is improved, and ATP production is further increased, while the deleterious consequences of acidosis and of Ca2+ overload are limited.
COMPOSITION
ANGIRID MR : Each modified release tablet contains Trimetazidine Hydrochloride BP 35 mg.
INDICATIONS
Long-term treatment of angina pectoris.
DOSAGE & ADMINISTRATION
1 tablet at mealtimes in the morning and evening.
SIDE EFFECTS
Rare cases of gastrointestinal disorders.
CONTRAINDICATIONS
Trimetazidine is contraindicated in-patients with a known hypersensitivity to its components.
USE IN PREGNANCY AND LACTATION
Pregnancy : Studies in animals have not demonstrated ateratogenic effect. However, in the absence of clinical data and for safety reasons, prescription should be avoided during pregnancy. Breastfeeding : In the absence of data, breastfeeding is not recommended during treatment.
DRUG INTERACTIONS
No Drug Interactions so far have been reported. In particular, no interactions have been reported with beta-blocker, calcium antagonists, nitrates, heparin, hypolipidaemic agents or digitals preparation.
SUPPLY
Each box contains 3 x 10 tablets in blister strips